American Conference Institute’s (ACI) 28th Annual Conference on Drug & Medical Device Litigation

December 5 – 6, 2023

Troutman Pepper is proud to sponsor the American Conference Institute’s (ACI) 28th Annual Conference on Drug & Medical Device Litigation, taking place December 5-6, 2023, in New York City, NY.

Partner Eric Rumanek will be panelist on “Innovative Tactics for Persuading Juries that Pharma and Med Device Companies are Not Bad Actors,” on December 5, at 4:45 p.m.

The panel will discuss:

• Strategies for motions in limine: how to convince the court that your client should not be viewed the same as other defendants without negatively impacting your co-defendants’ cases?
• Trial presentation strategies for framing your narrative to reach today’s jurors.
• Overcoming juror biases and predispositions about life sciences companies in today’s social and political climate.
• Decreasing risks of extreme verdicts by changing the narrative.

ACI’s Drug and Medical Device Litigation conference is the life sciences industry’s premier products liability conference, providing invaluable information on the potential impact of newly proposed MDL rule changes, overcoming the challenges of plaintiff census forms and registries, and how new Rule 702 amendments will impact future strategies for offering expert testimony.

Gain insights on how the recent Supreme Court session may impact future preemption battles, as well as tactical tools for combatting “non-traditional” liability claims, bet-the-company litigations, and the increasing liability risks associated with new, cutting edge MedTech.